Pfizer
NYSE PFE · New York, NY
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Pfizer is a clinical trial sponsor based in New York, NY, listed as NYSE PFE. It has 238 active clinical trials with 23,591,935 planned participants, across 17 therapeutic areas. Since 2021 it has completed 774 trials and stopped 191 early. Its FDA record on file shows 1 recall.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · NYSE PFE
Fundraising
Pipeline · 238 active trials
| Stage | Trial | Status |
|---|---|---|
On the market · 43 products
- SUTENT sunitinib malate · NDA 021938 · prescription
- GENOTROPIN PRESERVATIVE FREE somatropin · BLA 020280 · prescription
- GENOTROPIN somatropin · BLA 020280 · prescription
- TIKOSYN dofetilide · NDA 020931 · prescription
- TALZENNA talazoparib tosylate · NDA 217439 · prescription
- ZITHROMAX azithromycin · NDA 050710 · prescription
- ZITHROMAX azithromycin · NDA 050711 · prescription
- INLYTA axitinib · NDA 202324 · prescription
- LOMOTIL atropine sulfate, diphenoxylate hydrochloride · NDA 012462 · prescription
- IDARUBICIN HYDROCHLORIDE idarubicin hydrochloride · NDA 050734 · prescription
- IDAMYCIN PFS idarubicin hydrochloride · NDA 050734 · prescription
- CYTOMEL liothyronine sodium · NDA 010379 · prescription
- HYMPAVZI marstacimab-hncq · BLA 761369 · prescription
- ZARONTIN ethosuximide · ANDA 080258 · prescription
- CADUET amlodipine besylate, atorvastatin calcium · NDA 021540 · prescription
- CHANTIX varenicline tartrate · NDA 021928 · prescription
- FRAGMIN dalteparin sodium · NDA 020287 · prescription
- EUCRISA crisaborole · NDA 207695 · prescription
- PREMARIN estrogens, conjugated · NDA 004782 · prescription
- PREMARIN estrogens, conjugated · NDA 010402 · prescription
- PREMARIN estrogens, conjugated · NDA 020216 · prescription
- BESPONSA inotuzumab ozogamicin · BLA 761040 · prescription
- ZITHROMAX azithromycin · NDA 050784 · prescription
- HEPARIN SODIUM PRESERVATIVE FREE heparin sodium · NDA 201370 · prescription
- LITFULO ritlecitinib tosylate · NDA 215830 · prescription
- DILANTIN phenytoin · ANDA 084427 · prescription
- PRISTIQ desvenlafaxine succinate · NDA 021992 · prescription
- CEREBYX fosphenytoin sodium · NDA 020450 · prescription
- FLAGYL metronidazole · NDA 020334 · prescription
- MYLOTARG gemtuzumab ozogamicin · BLA 761060 · prescription
- LEVOXYL levothyroxine sodium · NDA 021301 · prescription
- PROTONIX pantoprazole sodium · NDA 022020 · prescription
- XALKORI crizotinib · NDA 217581 · prescription
- ALDACTONE spironolactone · NDA 012151 · prescription
- NIVESTYM filgrastim-aafi · BLA 761080 · prescription
- TRAZIMERA trastuzumab-qyyp · BLA 761081 · prescription
- TOVIAZ fesoterodine fumarate · NDA 022030 · prescription
- PROTONIX pantoprazole sodium · NDA 020987 · prescription
- PROTONIX IV pantoprazole sodium · NDA 020988 · prescription
- SILVADENE silver sulfadiazine · NDA 017381 · prescription
- ABRYSVO respiratory syncytial virus vaccine · BLA 125769 · prescription
- PENBRAYA meningococcal groups a, b, c, w, and y vaccine · BLA 125770 · prescription
- TICOVAC tick-borne encephalitis vaccine · BLA 125740 · prescription
Questions about Pfizer
No warning letter naming Pfizer is on file. FDA has published 1 recall naming it.
Yes. FDA's enforcement reports list 1 recall by Pfizer; the latest, reported on 2026-09-23, is a Class II recall.
Pfizer is lead sponsor of 238 active clinical trials on ClinicalTrials.gov, with 23,591,935 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 774 trials and stopped 191 early.
Pfizer is based in New York, NY and is listed as NYSE PFE. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Pfizer; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-09-23.
Approve Suite is not affiliated with Pfizer. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.